Data / Drug companies / Rugby Laboratories
Rugby Laboratories: 156 products in the FDA NDC directory, labeler code 0536
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Rugby Laboratories (labeler code 0536) lists 156 products in the FDA National Drug Code Directory, covering 90 finished drugs by generic name. By type: 156 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on October 12, 2026.
The request: Watch Rugby Laboratories (FDA labeler code 0536): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 0536
- Products in commercial distribution
- 156
- Packages
- 219
- Finished drugs by generic name
- 90
- Prescription products
- 0
- Over the counter products
- 156
- Flagged as original packager
- 125 of 125 products that carry the flag
- Started marketing in the last 12 months
- 11
- Products with a marketing end date set
- 9
- Earliest marketing start
- December 19, 1992
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 98 | 62.8% |
| Generic drugs (ANDA) | 50 | 32.1% |
| New drug applications (NDA) | 5 | 3.2% |
| Other unapproved drugs | 2 | 1.3% |
| Authorized generics (NDA) | 1 | 0.6% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 156 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 15 | 9.6% |
| Cream | 14 | 9% |
| Liquid | 12 | 7.7% |
| Gum, chewing | 10 | 6.4% |
| Tablet, film coated | 10 | 6.4% |
| Solution/ drops | 8 | 5.1% |
| Ointment | 8 | 5.1% |
| Gel | 8 | 5.1% |
| Tablet, chewable | 7 | 4.5% |
| Tablet, extended release | 7 | 4.5% |
| Solution | 6 | 3.8% |
| Spray, metered | 5 | 3.2% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Guaifenesin and Pseudoephedrine HCl | 0536-1488 | Tablet, extended release | Generic drugs (ANDA) | October 12, 2026 |
| Rugby allergy relief d | 0536-1491 | Tablet, film coated, extended release | Generic drugs (ANDA) | July 8, 2026 |
| Rugby mucus relief er | 0536-1489 | Tablet, multilayer, extended release | Generic drugs (ANDA) | June 15, 2026 |
| Lubricant Eye | 0536-1476 | Solution/ drops | Over the counter monograph drugs | May 14, 2026 |
| Cough Suppressant Adult | 0536-1480 | Capsule, liquid filled | Over the counter monograph drugs | May 8, 2026 |
| Athletes Foot | 0536-1481 | Aerosol, spray | Over the counter monograph drugs | May 1, 2026 |
| Senna | 0536-1483 | Solution | Over the counter monograph drugs | April 17, 2026 |
| Rugby Pain Relieving Analgesic | 0536-1477 | Cream | Over the counter monograph drugs | March 3, 2026 |
| Olopatadine HCl | 0536-1478 | Solution/ drops | Generic drugs (ANDA) | January 15, 2026 |
| Budesonide | 0536-1456 | Spray, metered | Generic drugs (ANDA) | December 1, 2025 |
| Nasal Allergy | 0536-1457 | Spray, metered | Generic drugs (ANDA) | November 11, 2025 |
| Rugby Benzoyl Peroxide Wash Acne Medication | 0536-1474 | Lotion | Over the counter monograph drugs | October 31, 2025 |
| Rugby Benzoyl Peroxide Acne Medication | 0536-1459 | Gel | Over the counter monograph drugs | October 31, 2025 |
| Rugby Mucus Relief ER | 0536-1451 | Tablet, multilayer, extended release | Generic drugs (ANDA) | June 17, 2025 |
| Mucus Relief ER | 0536-1249 | Tablet, extended release | Generic drugs (ANDA) | April 21, 2025 |
| Rugby mucus relief dm er | 0536-1447 | Tablet, extended release | Generic drugs (ANDA) | April 16, 2025 |
| Rugby omeprazole | 0536-1448 | Tablet, delayed release | New drug applications (NDA) | April 15, 2025 |
| Olopatadine Hydrochloride | 0536-1445 | Solution/ drops | Generic drugs (ANDA) | April 15, 2025 |
| Rugby Mucus Relief D | 0536-1449 | Tablet, multilayer, extended release | Generic drugs (ANDA) | April 2, 2025 |
| Rugby Mucus Relief DM ER | 0536-1446 | Tablet, extended release | Generic drugs (ANDA) | April 2, 2025 |
| Clotrimazole | 0536-1443 | Solution | Over the counter monograph drugs | November 21, 2024 |
| Acetaminophen | 0536-1413 | Tablet, film coated | Over the counter monograph drugs | October 3, 2024 |
| Nicotine | 0536-5896 | Patch | Generic drugs (ANDA) | June 25, 2024 |
| Nicotine | 0536-5895 | Patch | Generic drugs (ANDA) | June 25, 2024 |
| Nicotine | 0536-5894 | Patch | Generic drugs (ANDA) | June 25, 2024 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.